In NIH-Cosponsored Mpox Virus Study In Congo, SIGA Technologies’ Antiviral Tecovirimat Did Not Improve Lesion Resolution, Stock Tanks
In NIH-Cosponsored Mpox Virus Study In Congo, SIGA Technologies' Antiviral Tecovirimat Did Not Improve Lesion Resolution, Stock TanksOn Thursday, the ...
